Tag: Intravenous access

While extravasation of vesicant chemotherapy is a rare but significant complication that can cause severe tissue damage, preventing it is paramount in oncology care. Identifying **which is the most effective method of administering a chemotherapeutic agent that is a vesicant** is a critical aspect of patient safety and successful treatment delivery.

With more than 25 million patients receiving peripheral intravenous (IV) catheters annually in U.S. hospitals, infusion therapy is a routine medical procedure. However, this common treatment is not without potential pitfalls, and understanding **what are the problems with infusion therapy** is crucial for both healthcare providers and patients to ensure a safer and more effective experience.

Over 90% of all hospitalized patients will receive an IV at some point during their stay. While a common sight, this practice prompts the question: "Why do hospitals always give IVs?" The answer lies in the profound pharmacological and physiological advantages of bypassing the digestive system for speed, precision, and effectiveness.

Permanent intravenous (IV) access is a critical component of care for thousands of patients undergoing long-term treatment. For those unfamiliar with medical terminology, the phrase '**what is a permanent IV called?**' often leads to a variety of names for advanced vascular access devices, such as implanted ports, tunneled catheters, and PICC lines. These devices are essential for delivering medications, fluids, and nutrition directly into the bloodstream over extended periods, often months or even years.